| P50 | author | Jeremy D Keenan | Q61161084 |
| | Bruce Gaynor | Q87280420 |
| | Travis C. Porco | Q87281091 |
| | Thomas M Lietman | Q87281221 |
| | Paul M. Emerson | Q55176139 |
| P2860 | cites work | Azithromycin and the risk of cardiovascular death | Q24604355 |
| | Antibiotic selection pressure and macrolide resistance in nasopharyngeal Streptococcus pneumoniae: a cluster-randomized clinical trial | Q28476520 |
| | On estimating efficacy from clinical trials | Q33523091 |
| | Ten years left to eliminate blinding trachoma | Q34284904 |
| | Association of mass treatment with azithromycin in trachoma-endemic communities with short-term reduced risk of diarrhea in young children | Q35246081 |
| | Effect of mass distribution of azithromycin for trachoma control on overall mortality in Ethiopian children: a randomized trial | Q37854366 |
| | Assessment of herd protection against trachoma due to repeated mass antibiotic distributions: a cluster-randomised trial | Q37855263 |
| | Effect of a single mass antibiotic distribution on the prevalence of infectious trachoma | Q37862751 |
| | Mass distribution of azithromycin for trachoma control is associated with short-term reduction in risk of acute lower respiratory infection in young children | Q43939528 |
| P433 | issue | 9 | |
| P921 | main subject | azithromycin | Q165399 |
| P304 | page(s) | 821-823 | |
| P577 | publication date | 2013-05-01 | |
| P1433 | published in | JAMA Internal Medicine | Q177428 |
| P1476 | title | Adult mortality in a randomized trial of mass azithromycin for trachoma | |
| P478 | volume | 173 | |